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INTRODUCTION
The genus Megalocytivirus in the family
Iridoviridae encompasses several viral isolates
such as red sea bream iridovirus (RSIV), sea
bass iridovirus (SBIV), African lampeye
iridovirus (ALIV), dwarf gourami iridovirus (DGIV),
grouper sleepy disease iridovirus (GSDIV), Tai-
wan grouper iridovirus (TGIV), and infectious
spleen and kidney necrosis virus (ISKNV), which
are genetically identical (Chinchar et al., 2005).
In our previous study (Mahardika et al., 2004),
we performed artificial infection in juvenile
humpback grouper with grouper sleepy dis-
ease iridovirus (GSDIV). As a result, the mortal-
ity was lower in the groups injected with the
primary filtrate than in groups receiving the
10–4 diluted inoculum. Electron microscopy
revealed the presence of many unusual inclu-
sion body-bearing cells (IBCs) containing ab-
normal inclusion body with a small number of
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ABSTRACT
The genus Megalocytivirus in the family of Iridoviridae encompasses isolate of red
sea bream iridovirus (RSIV). In the present study, grunt fin (GF) cells were treated with
red sea bream iridovirus (RSIV) in combinations with interferons (IFNs) and splenic
substances. The viral titer in the combination with primary splenic substance was
higher than the other combinations of 10-1 and 10-2 diluted splenic substances, and
the positive control. The viral titer was not decreased by all combinations with
recombinant murine interferon-α (rMuIFN-α), recombinant murine IFN-β (rMuIFN-β), and
recombinant feline interferon-ω (rFeIFN-ω). Electron microscopy revealed inclusion
body bearing cells (IBCs) and enlarged cells allowing virus propagation within the
intracytoplasmic virus assembly site (VAS). Most were enlarged cells. These enlarged
cells were divided into three cell types. Cells of Type II, which contained many
mature virions within the VAS, were numerous in number in all treated cells. Cells of
Type I allowing assembly of few virions and cells of Type III containing many immature
viral particles were rather fewer in number. Their percentage was almost the same in
all combinations with the splenic substances and IFNs. These results determined in
in vitro treatment with IFNs did not prevent viral replication of RSIV, as well as the
splenic substances which were derived from the RSIV-infected spleen of red sea
bream did not contain any factors to disturb RSIV replication.
KEYWORDS: red sea bream, iridovirus, grunt fin, splenic substances,
interferons, ultra structural analysis
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deformed virions in the former groups. This
impaired virus assembly and appeared to pre-
vent mortality in the challenged fish and was
assumed to be due to an interferon-like effect
of a previously unknown substance that was
passed with a filtrate from the donor fish.
In order to prove this hypothesis, we per-
formed in vitro tests using grunt fin (GF) cells
and semi-purified RSIV (red sea bream iridovirus)
derived from samples of infected red sea
bream in combinations with the splenic
substances derived from the red sea bream
infected with RSIV, recombinant murine
interferon-α (rMuIFN-α), recombinant murine
IFN-β (rMuIFN-β), and recombinant feline
interferon-ω (rFeIFN-ω). IFN-α and IFN-β are
known to be potential for endogenous antivi-
ral cytokines that suppress the replication of
viruses such as murine leukaemia virus (MuLV:
genus Gammaretrovirus, family Retroviridae)
(Pitha et al., 1979), human herpes simplex
virus type 1 (HSV-1; genus Simplexvirus, family
Herpesviridae) (Härle et al., 2002; Sainz &
Halford, 2002), severe acute respiratory
syndrome-associated coronavirus (SARS-CoV;
genus Coronavirus, family Coronaviridae)
(Sainz et al., 2004). Other type of IFN such as
rFeIFN-ω has clinical anti-viral activity for
feline calicivirus and herpesvirus (Yamamoto
et al., 1990; Uchino, 1997) as well as canine
parvovirus (Uchino, 1997; Ishiwata et al., 1998)
and akoya-virus infected Japanese pearl oys-
ters Pinctada fucata martensii (Miyazaki et al.,
2000). This paper describes the results of the
viral titer and ultrastructural features of the
RSIV-infected GF cells treated with the splenic
substances and various IFNs.
MATERIALS AND METHODS
Cell Culture
GF (grunt fin) cells were used in this study.
GF cells were grown in 25 cm2 cell culture
flasks at 25oC to confluence in Eagle’s mini-
mum essential medium (MEM: Nissui, Japan)
supplemented with fetal bovine serum (FBS:
Sigma, USA), L-glutamine, and buffered with
NaHCO to pH 7.2-7.4. For routine passage and
virus inoculation, 10% and 2% FBS was added
to the medium (MEM-10 and 2), respectively.
Preparation of Viral Inoculum and
Splenic Substances
Semi-purified virus was prepared from the
spleens of the RSIV-infected red sea bream
from a mariculture farm in Mie Prefecture, Ja-
pan, likewise our previous preparation of semi-
purified virus (Mahardika & Miyazaki, 2009) but
with some modifications. The procedures were
as follows: A total of 0.6 g of swollen spleens
from the diseased fish was homogenized in 6
mL of MEM-2 containing antibiotics (penicillin
50 IU mL-1 and streptomycin 50 μg mL-1) in a
glass homogenizer. The obtained homogenate
was confirmed to be RSIV-positive by PCR
assay described by Kurita et al. (1998). The
homogenate was centrifuged (CT4D Himac,
Hitachi, Japan) at 1,200 x g for 15 min. at room
temperature, and the supernatant was filtered
(450 nm). The obtained filtrate was diluted to
be a final volume of 12 mL and ultracentrifuged
(L-70 Ultracentrifuge, Beckman, USA) at
100,000 x g for 10 min. at 4oC. The superna-
tant was collected, filtered (450 nm) and used
as the primary splenic substance. This sub-
stance was diluted 10 and 100 times (10-1 and
10-2 dilution) with MEM-2.
The sediment was resuspended in 12 mL
of MEM-2 containing antibiotics and ultra-
centrifuged at 100,000 x g for 10 min. at 4oC.
Then, the recovered sediment was resus-
pended in 5 mL of MEM-2 containing antibiot-
ics and filtered (450 nm). The obtained semi-
purified virus was used for an inoculum al-
though, as the result, the virus concentration
was decreased in number by repeated ultra-
centrifugation.
Interferons (IFNs)
An amount of 105 units vial-1 of rMuIFN-α
and rMuIFN-β (PBL Biomedical Laboratories, New
Brunswick, NJ.), and 10 mega units of rFeIFN-ω
(Toray, Japan) were dissolved with MEM.
Treatments
Two treatments were performed. The first
was treatment with the splenic substances
using five tubes: 0.1 mL of the semi-purified
virus inoculum mixed into each of the four
tubes containing 0.2 mL of different dilutions
of the splenic substances (primary, 10-1, 10-2
dilution) and MEM-2 as positive control, respec-
tively. In the fifth tube, the same volume of the
primary splenic substances and MEM-2 were
mixed as negative control. These five mixtures
were kept at room temperature for 15 min., and
inoculated into monolayer of GF cells for 1 hour
at 25oC, followed by adding the MEM-2 to a
final volume of 5 mL. This treatment was re-
peated two times.
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The second was treatment with IFNs and
set in two trials. First trial consisted of five
tubes: 0.1 mL of the semi-purified virus inocu-
lum was mixed into each of the five tubes,
which contained 0.1 mL of different concen-
trations of rMuIFN-α (104 and 103 units mL-1),
rMuIFN-β (104 and 103 units mL-1) and MEM as
control, respectively. The second trial consist-
ing of three tubes: 0.1 mL of the semi-purified
virus inoculum was mixed into each of the three
tubes which contained 0.1 mL of rMuIFN-β (105
units mL-1), rFeIFN-ω (106 units mL-1) and MEM as
control, respectively. This second trial was
repeated two times. All mixtures were kept at
room temperature for 15 min., and inoculated
into monolayer of GF cells for 1 hour at 25oC,
followed by adding the MEM-2 to reach 5 mL.
The final concentration of both rMuIFN-α and
rMuIFN-β was 2 x 102 and 2 x 101 units mL-1 in
the first trial. In the second trial, the final con-
centration was 2 x 103 units mL-1 of rMuIFN-β
and 2 x 104 units mL-1 of rFeIFN-ω.
Monolayer of GF cells were infected with
semi-purified virus inoculum at a multiplicity
of infection (MOI) of approximately 0.5-1.
Infected cells were incubated at 25oC. The
rounded and enlarged cells were harvested
by shaking the culture medium in order to sepa-
rate these cells from the monolayer at 6 days
post infection (p.i.). The recovered cells were
used for virus titration and electron micros-
copy (EM).
Virus Titration
Viral titration in RSIV-infected GF cells was
conducted using the TCID50 method with GF
cells grown in 96-well tissue culture plates.
This assay was analyzed in duplicate.
Electron Microscopy
For transmission electron microscopy, a 3.5
mL of harvested medium containing RSIV-in-
fected GF cells were centrifuged at 1,200 x g
for 10 min. The obtained pellets were fixed with
70% Karnovsky’s solution (1.6 g paraformalde-
hyde in 20 mL distilled water, 2 mL of 70% glut-
araldehyde, 35 mL of 0.2 M phosphate-buffered
saline, and 13 mL distilled water), post-fixed in
1% OsO4 and processed for electron micros-
copy, as previously described by Mahardika et
al. (2008). Rounded and enlarged cells con-
tained within 800 mm2 of the semi-thin section
per sample were examined. These cells were
counted at an instrument magnification of
5,000X to 10,000X. The data were expressed
as percentage per cells. All of obtained data
were evaluated using fisher’s exact test.
RESULTS AND DISCUSSION
Viral Propagation in Combination
With The Splenic Substances
The viral titers in combination with the pri-
mary splenic substance were higher (104.93 and
105.2 TCID50 mL
-1) than the other combinations
with splenic substances at (10-1 dilution: 104.6
and 104.9 TCID50 mL
-1, and 10-2 dilution: 104.6 and
104.8 TCID50 mL
-1), positive control (104.6 and
104.8 TCID50 mL
-1), and negative control (101.3
and 101.7 TCID50 mL
-1) in the two examinations
at 6 d p.i. (Figure 1).
Viral Propagation in Combination
with IFNs
The viral titers were 104.8 TCID50 mL
-1 in both
combinations with 2 x 102 and 2 x 101 units mL-1
of rMuIFN-α at 6 d p.i. In the combination with 2
x 102 and 2 x 101 units mL-1 of rMuIFN-β, the
viral titers were 104.8 and 104.9 TCID50 mL
-1.
These viral titers were similar to the control
(104.9 TCID50 mL
-1) (Figure 2a). In combination
with 2 x 103 units mL-1 of rMuIFN-β, the viral
titers were 104.9 and 105.1 TCID50 mL
-1 in the two
examinations. In combination with 2 x 104 units
mL-1 of rFeIFN-ω, the viral titers were 104.8 and
105.1 TCID50 mL
-1 in the two examinations. These
viral titers were similar to the control (104.9 and
105.1 TCID50 mL
-1) (Figure 2b).
Electron Microscopic Features of GF
Cells Treated with RSIV and Splenic
Substances
Electron microscopic examination of GF
cells, which were treated with mixture of semi-
purified virus and different dilution of the
splenic substances revealed IBCs and necrotic
cells allowing virus propagation within the
intracytoplasmic virus assembly site (VAS) at 6
d p.i. IBCs were observed a few in the number
(2.1%-5.7%) (Table 1). Some small cells were also
observed forming the intracytoplasmic VAS
containing a small number of virus particles
(10.8%-12.7%). Most were enlarged cells (83.0%-
86.6%) and had fragmented nuclei whose com-
ponents were assimilated with the cytoplasm,
resulting in the disappearance of the nuclei.
These cells developed intracytoplasmic VAS
within which many virions were propagated.
These enlarged cells were divided into three
cell types. Cell type-I allowed development of
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the VAS, which showed the assembly of a few
number of virions (less than 20). Cell type-II
had assembled many mature virions (more than
20) within the VAS. Cell type-III contained many
immature viral particles (more than 20) within
the VAS. In the GF cells treated with the mix-
ture of semi-purified virus inoculum and differ-
ent dilution of the splenic substances (primary,
10-1 and 10-2), the percentages of cell type-I
and cell type-III were 11.6%-18.8% and 2.9%-
10.6%, respectively, which were lesser than
cell type-II (75.8%-85.5%). The percentages of
these cell types were similar (P>0.05) to the
positive control (Table 2, Figure 3 & 4).
Electron Microscopic Features of GF
Cells Treated with RSIV and IFNs
Electron microscopic examination of the
GF cells treated with mixture of semi-purified
virus and various IFNs focused to the enlarged
cells. In combination with rMuIFN-α and rMuIFN-
Figure 2. Viral titers of RSIV in combination with IFNs in two set trials. A: Viral titers of RSIV in
combination with two different concentrations of rMuIFN-α and rMuIFN-β at
6 d p.i. (A) In combination with 2 x 102 unit mL-1 of rMuIFN-α, (B) In combination with 2 x
101 unit mL-1 of rMuIFN-α, (C) In combination with 2 x 102 unit mL-1 of rMuIFN-β, (D) In
combination with 2 x 101 unit mL-1 of rMuIFN-β, and (E) Control. B: Viral titers of RSIV in
combination with rMuIFN-β and rMuIFN-ω in the two examinations at 6 d p.i. (A) In
combination with 2 x 103 unit mL-1 of rMuIFN-β, (B) In combination with 2 x 104 unit
mL-1 of rMuIFN-ω, and (C) Control. Data was analyzed in duplicate and error bars show
standard deviation (SD)
Figure 1. Viral titers of RSIV in combination with splenic substances in two examinations at
6 d p.i. (A) In combination with primary splenic substance, (B) In combination with
10-1 dilution of splenic substance, (C) In combination with 10-2 dilution of splenic
substance, (D) Positive control, (E) Negative control. Data was analyzed in dupli-
cate and error bars show standard deviation (SD)
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β (2 x 102 and 2 x 101 units mL-1), the percent-
ages of cell type-I and cell type-III were lesser
(13.5%–14.9% and 3.4%-4.4%) than cell type-II
(81.0%-82.7%), which was almost same (P>0.05)
as the control (Table 3, Figure 5). Some of cell
type-I in combination with 2 x 102 units mL-1 of
rMuIFN-α contained tubule structures among
immature viral particles within the VAS.
In the combinations with rMuIFN-β and
rFeIFN-ω (2 x 103 and 2 x 105 units mL-1), the
percentages of cell type-I and cell type-III were
17.7%-18.1% and 5.9%-6.9%, respectively,
which were lesser than cell type-II (75.3%-
76.0%). The percentages of these cell types
were similar (P>0.05) to the positive control
(Table 4).
Table 1. Electron microscopic cell count of different types of cells with virus particles
derived from RSIV-infected GF cells in combination with splenic substances in vitro
IBCs were included in the enlarged cells with virus particles. I: First examination, II: Second examination
Table 2. Electron microscopic cell count of different types of enlarged cells with virus
particles derived from RSIV-infected GF cells in combination with splenic substances
in vitro
I: First examination, II: Second examination
Enlarged cells IBCs Small round cells
I 83.8 5.4 10.8
II 86.6 2.1 11.3
I 86.1 3.2 10.8
II 83.0 5.7 11.3
I 85.2 3.1 11.7
II 85.3 2.9 11.8
I 84.1 3.5 12.4
II 83.6 3.6 12.7
In combination with 10-2 dilution of 
splenic substance 
In combination with MEM-2 (positive 
control)
Samples
Different  types of cells with virus 
part icles ( % )
In combination with primary splenic 
substance
In combination with 10-1 dilution of 
splenic substance 
ECs with 
many 
mature 
virions
ECs with 
many 
immature 
virus 
part icles
ECs with 
a few 
number 
of  
virions
I 77.6 9.5 12.9 87.9 12.1
II 75.8 10.6 13.6 85.7 14.3
I 77.9 5.4 16.8 89.8 10.2
II 84.7 3.7 11.7 88.4 11.6
I 76.7 4.5 18.8 89.3 10.7
II 85.5 2.9 11.6 89.6 10.4
I 80.7 3.9 15.5 87.1 12.9
II 84.9 3.2 11.8 86.9 13.1
Different  types of enlarged 
Total 
ECs 
(%)
Total small 
round 
cells with 
virus
part icles 
(%)
Samples
In combination with primary 
splenic substance
In combination with 10-1 
dilution of splenic  substance 
In combination with 10-2 
dilution of splenic  substance 
In combination with MEM-2 as 
positive control
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Figure 3. (A-B) Electron micrographs of IBC and cells derived from RSIV-infected GF cells in
combination with splenic substances at 6 d p.i. (A) Mature IBC in the combination with
primary splenic substance has a large inclusion body with a VAS containing a mass of
coarse granules (c) and multiple virus particles (scale bar =  2,900 nm). (B) Enlarged
cells in combination with 10-2 dilution of splenic substance. One elarged cell (upper)
has a disappearance of the nucleus and development of an intracytoplasmic VAS in
which many virus particles are present. Another is small cell. This cell forms an
intracytoplasmic VAS containing a small number of virus particles (scale bar = 2,400
nm). f: mass of fine granules; n: nucleus of host cell; VAS: virus assembly site
Figure 4. Electron micrographs of enlarged cells derived from RSIV-infected GF cells in the
combination with splenic substances at 6 d p.i. (A) Cell type-I in control allows devel-
opment of the VAS, which shows the assembly of a few number of virions (less than
20) (scale bar = 2,400 nm). (B) Cell type-II in the combination with primary splenic
substance has a disappearance of the nucleus and development of an intracyto-
plasmic VAS that propagation of many mature virions (more than 20) takes place
(scale bar = 2,400 nm). (C) Cell type-III in the combination with 10-1 dilution splenic
substance has an intracytoplasmic VAS, within which many immature viral particles
(more than 20) takes place (scale bar = 1,500 nm). (D) Detail of an intracytoplasmic
VAS in a cell type-III. Assembly of immature RSIV particles is evident within the VAS
comprising granules and microfilaments. Tubular structures are also formed (scale
bar = 600 nm)
C
A
D
B
A B
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Figure 5. Electron micrographs of enlarged cells derived from RSIV-infected GF cells in com-
bination with IFNs at 6 d p.i. (A) Cell type-I in combination with 2 x 102 unit mL-1 of
rMuIFN-α has a developed intracytoplasmic VAS with a small number of virus par-
ticles as well as a disappearance of the nucleus (scale bar = 1,500 nm). (B) Cell type-
I in combination with 2 x 102 unit mL-1 of rMuIFN-α has a developed intracytoplasmic
VAS in which masses of coarse (c), a small number of virus particles and tubule
structures takes place (scale bar = 2,000 nm). (C) Cell type-II in combination with 2
x 102 unit mL-1 of rMuIFN-α has a disappearance of the nucleus and development of
an intracytoplasmic VAS, within which masses of coarse (c) and fine granules, and
many mature virions take place (scale bar = 1,200 nm). (D) Cell type-III in combina-
tion with 2 x 101 unit mL-1 of rMuIFN-α has an intracytoplasmic VAS, within which
many immature viral particles take place (scale bar = 1,300 nm)
Table 4. Electron microscopic cell count of different types of enlarged cells with virus particles
derived from RSIV-infected GF cells in combination with interferons (rMuIFN-β and
rFeIFN-ω) in vitro
IBCs were included in the enlarged cells with virus particles. I: First examination, II: Second examination
ECs with 
many 
mature 
virions
ECs with 
many 
immature 
virus 
part icles
ECs with 
a few 
number 
of 
virions
I 75.4 6.9 17.7 87.3 12.7
II 76.0 5.9 18.1 85.5 14.5
I 75.3 6.6 18.1 86.0 14.0
II 75.5 6.5 17.9 88.0 12.0
I 77.9 4.6 17.6 88.5 11.5
II 77.8 4.0 18.2 87.1 12.9
In combination with 2 x 104 
UmL-1 of rMuIFN-
In combination with MEM 
(control)
Different  t ypes of enlarged 
Total 
ECs 
(%)
Total small 
round cells 
w ith 
virus 
part icles 
(%)
Samples
In combination with 2 x 103 
UmL-1 of rMuIFN- β
ω
A B
C D
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In the present study, inoculated RSIV in-
fected GF cells and produced cellular enlarge-
ment as a definite cytopathic effect in all
combinations with the splenic substances and
IFNs. The viral titer in combination with primary
splenic substances was higher than the other
combinations of 10-1 and 10-2 diluted splenic
substances, and positive control. The viral ti-
ter was not decreased by all combinations with
rMuIFN-α, rMuIFN-β, and rFeIFN-ω. These results
determined in vitro treatment with INFs did not
prevent viral replication of RSIV, as well as the
splenic substances which were derived from
the RSIV-infected spleen of red sea bream, did
not contain any factors that could disturb RSIV
replication. In EM examination, IBCs seen in
the GF cells that were infected with RSIV in
combination with different dilutions of the
splenic substances were same to those seen
in the previous study (Mahardika & Miyazaki,
2009) as well as megalocytivirus-infected
cells, in vivo (Jung et al., 1997; Sudthongkong
et al., 2002a; 2002b; Mahardika et al., 2004;
2008; Miyazaki, 2007). Enlarged cells were also
derived from RSIV-infected GF cells and
allowed assembly of viral particles in the intra-
cytoplasmic VAS. Cells of type II, which
contained many mature virions within the VAS,
were numerous in number in all treated cells.
Cells of type I allowing assembly of a few
virions and cells of type III containing many
immature viral particles were rather small in the
number. Their percentages were almost the
same in all combinations with the splenic
substances and IFNs. IFN-α and IFN-β are known
to be potential as endogenous antiviral
cytokines that suppress the replication of
viruses (Pitha et al., 1979; Härle et al., 2002;
Sainz & Harford, 2002; Sainz et al., 2004).
rFeIFN-ω has clinical anti-viral activities
(Yamamoto et al., 1990; Uchino, 1997; Ishiwata
et al., 1998; Miyazaki et al., 2000). In the
present study, there were cells with the for-
mation of many immature viral particles within
the VAS as cell type III, and cells with slight
virion assembly as cell type I. However, be-
cause these cells were small in number, they
did not appear to be resulted in prevention of
viral replication. These results indicate that
the in vitro treatment with IFNs (rMuIFN-α,
rMuIFN-β, and rFeIFN-ω) did not affect on the
RSIV propagation in GF cells. Our in vivo study
(Mahardika et al., 2004) revealed that the
mortality rate in the fish injected with the
primary filtrate of the spleen of GSDIV-infected
grouper were lower than the fish received the
10–4 diluted inoculum. Results of our study in
vivo and in vitro resembled results of studies
by Sainz & Halford (2002) who revealed that
T-cell derived gamma interferon (IFN-γ) in-
hibited the replication of herpes simplex virus
type 1 (HSV-1; genus Simplexvirus, family
Herpesviridae) in vivo, while in vitro, HSV-1 was
highly resistant to the antiviral activity of IFN-
α/β or IFN-γ. Ellis (2001) reported that the cells
after in vivo infection produced interferon to
induce anti-viral defenses in neighboring cells,
which able to lyse virally infected cells and
reduce the rate of multiplication of virus within
them.
It was concluded that the examined IFNs
did not have antiviral efficacy to megalo-
cytivirus in vitro. Further in vivo studies using
IFNs will be needed to reveal real antiviral
effects of IFNs on RSIV.
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